CFTR and cystic fibrosis: Thus, we retrospectively evaluated clinical characteristics and outcome of CRMS/CFSPID infants carrying the D1152H pathogenetic variant, followed at five Italian reference CF centers in order to define the role of the second CFTR pathogenetic variant as a predictive factor of disease evolution.